142 related articles for article (PubMed ID: 30120731)
1. Transcription Factor 2I Regulates Neuronal Development via TRPC3 in 7q11.23 Disorder Models.
Deurloo MHS; Turlova E; Chen WL; Lin YW; Tam E; Tassew NG; Wu M; Huang YC; Crawley JN; Monnier PP; Groffen AJA; Sun HS; Osborne LR; Feng ZP
Mol Neurobiol; 2019 May; 56(5):3313-3325. PubMed ID: 30120731
[TBL] [Abstract][Full Text] [Related]
2. Consistent hypersocial behavior in mice carrying a deletion of
Martin LA; Iceberg E; Allaf G
Brain Behav; 2018 Jan; 8(1):e00895. PubMed ID: 29568691
[TBL] [Abstract][Full Text] [Related]
3. High-throughput screening identifies histone deacetylase inhibitors that modulate GTF2I expression in 7q11.23 microduplication autism spectrum disorder patient-derived cortical neurons.
Cavallo F; Troglio F; Fagà G; Fancelli D; Shyti R; Trattaro S; Zanella M; D'Agostino G; Hughes JM; Cera MR; Pasi M; Gabriele M; Lazzarin M; Mihailovich M; Kooy F; Rosa A; Mercurio C; Varasi M; Testa G
Mol Autism; 2020 Nov; 11(1):88. PubMed ID: 33208191
[TBL] [Abstract][Full Text] [Related]
4. The contribution of GTF2I haploinsufficiency to Williams syndrome.
Chailangkarn T; Noree C; Muotri AR
Mol Cell Probes; 2018 Aug; 40():45-51. PubMed ID: 29305905
[TBL] [Abstract][Full Text] [Related]
5. Loss of GTF2I promotes neuronal apoptosis and synaptic reduction in human cellular models of neurodevelopment.
Adams JW; Vinokur A; de Souza JS; Austria C; Guerra BS; Herai RH; Wahlin KJ; Muotri AR
Cell Rep; 2024 Mar; 43(3):113867. PubMed ID: 38416640
[TBL] [Abstract][Full Text] [Related]
6. Duplication of GTF2I results in separation anxiety in mice and humans.
Mervis CB; Dida J; Lam E; Crawford-Zelli NA; Young EJ; Henderson DR; Onay T; Morris CA; Woodruff-Borden J; Yeomans J; Osborne LR
Am J Hum Genet; 2012 Jun; 90(6):1064-70. PubMed ID: 22578324
[TBL] [Abstract][Full Text] [Related]
7. Williams-Beuren syndrome hypercalcemia: is TRPC3 a novel mediator in calcium homeostasis?
Letavernier E; Rodenas A; Guerrot D; Haymann JP
Pediatrics; 2012 Jun; 129(6):e1626-30. PubMed ID: 22566418
[TBL] [Abstract][Full Text] [Related]
8.
López-Tobón A; Shyti R; Villa CE; Cheroni C; Fuentes-Bravo P; Trattaro S; Caporale N; Troglio F; Tenderini E; Mihailovich M; Skaros A; Gibson WT; Cuomo A; Bonaldi T; Mercurio C; Varasi M; Osborne L; Testa G
Sci Adv; 2023 Dec; 9(48):eadh2726. PubMed ID: 38019906
[TBL] [Abstract][Full Text] [Related]
9. Intracisternal Gtf2i Gene Therapy Ameliorates Deficits in Cognition and Synaptic Plasticity of a Mouse Model of Williams-Beuren Syndrome.
Borralleras C; Sahun I; Pérez-Jurado LA; Campuzano V
Mol Ther; 2015 Nov; 23(11):1691-1699. PubMed ID: 26216516
[TBL] [Abstract][Full Text] [Related]
10. Disruption of Src Is Associated with Phenotypes Related to Williams-Beuren Syndrome and Altered Cellular Localization of TFII-I.
Sinai L; Ivakine EA; Lam E; Deurloo M; Dida J; Zirngibl RA; Jung C; Aubin JE; Feng ZP; Yeomans J; McInnes RR; Osborne LR; Roder JC
eNeuro; 2015; 2(2):. PubMed ID: 26464974
[TBL] [Abstract][Full Text] [Related]
11. Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioral and myelin alterations rescuable by a remyelinating drug.
Barak B; Zhang Z; Liu Y; Nir A; Trangle SS; Ennis M; Levandowski KM; Wang D; Quast K; Boulting GL; Li Y; Bayarsaihan D; He Z; Feng G
Nat Neurosci; 2019 May; 22(5):700-708. PubMed ID: 31011227
[TBL] [Abstract][Full Text] [Related]
12. Neuronal deletion of Gtf2i results in developmental microglial alterations in a mouse model related to Williams syndrome.
Bar E; Fischer I; Rokach M; Elad-Sfadia G; Shirenova S; Ophir O; Trangle SS; Okun E; Barak B
Glia; 2024 Jun; 72(6):1117-1135. PubMed ID: 38450767
[TBL] [Abstract][Full Text] [Related]
13. Action of TFII-I outside the nucleus as an inhibitor of agonist-induced calcium entry.
Caraveo G; van Rossum DB; Patterson RL; Snyder SH; Desiderio S
Science; 2006 Oct; 314(5796):122-5. PubMed ID: 17023658
[TBL] [Abstract][Full Text] [Related]
14. TFII-I regulates target genes in the PI-3K and TGF-β signaling pathways through a novel DNA binding motif.
Segura-Puimedon M; Borralleras C; Pérez-Jurado LA; Campuzano V
Gene; 2013 Sep; 527(2):529-36. PubMed ID: 23831514
[TBL] [Abstract][Full Text] [Related]
15. Essential role of the N-terminal region of TFII-I in viability and behavior.
Lucena J; Pezzi S; Aso E; Valero MC; Carreiro C; Dubus P; Sampaio A; Segura M; Barthelemy I; Zindel MY; Sousa N; Barbero JL; Maldonado R; Pérez-Jurado LA; Campuzano V
BMC Med Genet; 2010 Apr; 11():61. PubMed ID: 20403157
[TBL] [Abstract][Full Text] [Related]
16. A duplicated gene in the breakpoint regions of the 7q11.23 Williams-Beuren syndrome deletion encodes the initiator binding protein TFII-I and BAP-135, a phosphorylation target of BTK.
Pérez Jurado LA; Wang YK; Peoples R; Coloma A; Cruces J; Francke U
Hum Mol Genet; 1998 Mar; 7(3):325-34. PubMed ID: 9466987
[TBL] [Abstract][Full Text] [Related]
17. TFII-I/Gtf2i and Erythro-Megakaryopoiesis.
Gurumurthy A; Wu Q; Nar R; Paulsen K; Trumbull A; Fishman RC; Brand M; Strouboulis J; Qian Z; Bungert J
Front Physiol; 2020; 11():590180. PubMed ID: 33101065
[TBL] [Abstract][Full Text] [Related]
18. A mouse single-copy gene, Gtf2i, the homolog of human GTF2I, that is duplicated in the Williams-Beuren syndrome deletion region.
Wang YK; Pérez-Jurado LA; Francke U
Genomics; 1998 Mar; 48(2):163-70. PubMed ID: 9521869
[TBL] [Abstract][Full Text] [Related]
19. Gtf2i and Gtf2ird1 mutation do not account for the full phenotypic effect of the Williams syndrome critical region in mouse models.
Kopp N; McCullough K; Maloney SE; Dougherty JD
Hum Mol Genet; 2019 Oct; 28(20):3443-3465. PubMed ID: 31418010
[TBL] [Abstract][Full Text] [Related]
20. Essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development.
Enkhmandakh B; Makeyev AV; Erdenechimeg L; Ruddle FH; Chimge NO; Tussie-Luna MI; Roy AL; Bayarsaihan D
Proc Natl Acad Sci U S A; 2009 Jan; 106(1):181-6. PubMed ID: 19109438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
